FDA Warning Letter — Hikma Pharmaceuticals USA, Inc.
The FDA took a Warning Letter action against Hikma Pharmaceuticals USA, Inc. on February 6, 2012 (Eatontown, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Hikma Pharmaceuticals USA, Inc.
- Date
- February 6, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Center
- CDER
- Location
- Eatontown, NJ (United States)